Search company, investor...

synecor

synecor.com

Founded Year

2000

Stage

Unattributed VC - II | Alive

Total Raised

$25.5M

Last Raised

$10M | 12 yrs ago

About synecor

synecor is a medical device developer

Headquarters Location

3908 Patriot Drive Ste 170

Durham, North Carolina, 27703,

United States

919-541-9977

Missing: synecor's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: synecor's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

synecor Patents

synecor has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac surgery
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/22/2019

6/21/2022

Cardiac anatomy, Cardiac surgery, Cardiology, Congenital heart defects, Valvular heart disease

Grant

Application Date

9/22/2019

Grant Date

6/21/2022

Title

Related Topics

Cardiac anatomy, Cardiac surgery, Cardiology, Congenital heart defects, Valvular heart disease

Status

Grant

Latest synecor News

W.L. Gore & Associates launches GORE SYNECOR intraperitoneal biomaterial in Europe, The Middle East and South Africa

Feb 23, 2021

Gore & Associates launches GORE SYNECOR intraperitoneal biomaterial in Europe, The Middle East and South Africa The device was designed to address unmet needs in complex hernia repair, providing rapid vascularity3 and permanent strength with a low profile for single, effective hernia repair. GORE SYNECOR intraperitoneal biomaterial offers a tri-layer hybrid solution that supports single, effective hernia repair in complex patients. (Credit: PRNewswire / W. L. Gore & Associates, Inc. MPD Division) W. L. Gore & Associates (Gore) announced that GORE SYNECOR Intraperitoneal Biomaterial is now available in Europe, Middle East and South Africa. The device was designed to address unmet needs in complex hernia repair, providing rapid vascularity3 and permanent strength with a low profile for single, effective hernia repair. GORE SYNECOR Intraperitoneal Biomaterial is designed for ease of use during laparoscopic, robotic and open surgical procedures. The tri-layer hybrid material was first approved and launched in 2016 in the United States and received CE “This global expansion introduces a new category of synthetic hybrid material in Europe, Middle East and South Africa for surgeons to use in complex ventral hernia repair,” said David Lane, General Medical Products Business Leader at Gore. Bringing the latest innovations to hernia repair and abdominal wall reconstruction As pioneers in the mid-term bioabsorbable mesh category, Gore is persistent in the innovation of material solutions so that surgeons have quality material options when assessing the risk for complications in complex cases. GORE SYNECOR Intraperitoneal Biomaterial is flexible and conformable, with memory for easy unrolling, handling and optimal placement. The material absorbs bodily fluids and no pre-soaking is needed. The unique three layers of GORE SYNECOR Intraperitoneal Biomaterial are designed to promote rapid vascularity with minimal permanent material3 (data on file 2015; W. L. Gore & Associates, Inc; Flagstaff, AZ). Parietal Surface: Gore 3D PGA:TMC web scaffold generates high-quality tissue via rapid cellular infiltration. Vascularization is reported within seven days3 and tissue ingrowth within one month (data on file 2015; W. L. Gore & Associates, Inc; Flagstaff, AZ). Mid-Layer: Macroporous knit of dense monofilament PTFE fibers designed with a fiber diameter similar to lightweight mesh but with the strength of heavyweight mesh. Visceral surface: Non-porous PGA:TMC film provides intra–abdominal protection, minimizing the risk of adhesion formation to the material4 (data on file 2015; W. L. Gore & Associates, Inc; Flagstaff, AZ). To learn more, register to attend the Gore Complex Ventral Hernia Symposium on March 16, 2021. “I am very happy to see a new prosthetic material, with excellent clinical background and promising added-value in tissue integration under the new paradigm in minimally invasive abdominal wall reconstruction,” said Dr. Salvador Morales-Conde, General Digestive Surgeon, Chief of Innovation Unit, Sevilla, Spain. GORE SYNECOR Intraperitoneal Biomaterial is part of a portfolio of surgical devices featuring Gore’s proven synthetic material, including GORE® BIO-A® Tissue Reinforcement, GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement, GORE-TEX® Soft Tissue Patch and GORE® DUALMESH® Biomaterial. Source: Company Press Release

synecor Frequently Asked Questions (FAQ)

  • When was synecor founded?

    synecor was founded in 2000.

  • Where is synecor's headquarters?

    synecor's headquarters is located at 3908 Patriot Drive, Durham.

  • What is synecor's latest funding round?

    synecor's latest funding round is Unattributed VC - II.

  • How much did synecor raise?

    synecor raised a total of $25.5M.

  • Who are the investors of synecor?

    Investors of synecor include BD, Guidant Compass Group, Johnson & Johnson Innovation, Delphi Ventures, Frazier Healthcare Partners and 5 more.

  • Who are synecor's competitors?

    Competitors of synecor include Moximed, Cerapedics, Celonova Biosciences, Corpora Systems, InLight Solutions and 12 more.

Compare synecor to Competitors

N
NeuroTrax

NeuroTrax is a medical device and technology company.

C
Celonova Biosciences

CeloNova BioSciences is a global medical device company that develops, manufactures and markets a family of interventional cardiology and endovascular products, including its proprietary COBRA PzF Coronary Stent System. The company's interventional cardiology and endovascular products are currently available in more than fifty countries.

C
C2C

C2C is a medical device company developing a portfolio of medical devices.

ImpediMed Logo
ImpediMed

ImpediMed is a medical device company focusing on bioimpedance.

P
Precision Light

Precision Light is a stealth-mode medical device company

Moximed Logo
Moximed

Moximed is a developer of unicompartmental load absorber implants for active patients with painful knee osteoarthritis (OA). The Moximed implants do not require bone cutting or bone removal, and, importantly, they absorb excess joint load rather than shift load to other areas of the joint. The company is based in Fremont, California.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.